Results 231 to 240 of about 749,263 (385)

Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation. [PDF]

Cancer Cell Int, 2021
Wu Y, Gao J, Liu X.
europepmc   +1 more source

A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis

, 2013
Hengxiu Yan, Yong Wang, Xiaonong Yang, Lixin Fu, Dongmei Tang   +4 more
openalex   +2 more sources

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity in vitro and in vivo

Cancer Science, 2011
S. Tian, H. Quan, Cheng-ying Xie, Haiyi Guo, Fangfang Lü, Yongping Xu, Jin Li, L. Lou   +7 more
semanticscholar   +1 more source

Infusible Extracellular Matrix Biomaterial Enhances Cell‐Specific Pro‐Repair Responses Following Acute Myocardial Infarction

Advanced Healthcare Materials, EarlyView.
We measure the cell‐specific responses of administering infusible ECM (iECM) in acute myocardial infarction (MI) across multiple timepoints. Using single‐nucleus RNA sequencing and spatial transcriptomics, we measure macrophage activation, fibroblast remodeling, increased vascular development, lymphangiogenesis, cardioprotection, and neurogenesis ...
Joshua M. Mesfin, Alexander Chen, Quincy P. Lyons, Michael B. Nguyen, Maria L. Karkanitsa, Justin Yu, Van K. Ninh, Emily Gardner, Elyse G. Wong, Sriya N. Paleti, Julian Cheng, Benjamin D. Bridgelal, Kate E. Reimold, Selena Cao, Connor Uhre, Colin G. Luo, Zhenxing Fu, Kevin R. King, Karen L. Christman   +18 more
wiley   +1 more source

Activin A Prevents Hyperresponsiveness to Vascular Endothelial Growth Factor in Pathologic Blood Vessels by Perturbing the Trafficking of Activated Vascular Endothelial Growth Factor Receptor 2. [PDF]

Am J Pathol
Baccouche B, McCann M, Rajasekar J, Nhàn NTT, Yamada K, Kazlauskas A.   +5 more
europepmc   +1 more source

Novel Chalcones as Promising Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors

, 2023
Kamini Kashyap
openalex   +1 more source

Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents.

Pharmacology and Therapeutics, 2016
Beverly L. Falcón, Sudhakar Chintharlapalli, M. Uhlik, B. Pytowski   +3 more
semanticscholar   +1 more source

A Quantitative Printability Framework for Programmable Assembly of Pre‐Vascular Patterns via Laser‐Induced Forward Transfer

Advanced Healthcare Materials, EarlyView.
Laser‐Induced Forward Transfer (LIFT) is presented as a powerful micropatterning tool. An objective printability framework is developed to assess optimal printing parameter combinations. The technology is further explored for its ability to deterministically deposit microdroplets at predefined locations following CAD designs, enabling the patterning of
Cécile Bosmans, Núria Ginés Rodriguez, Ulisses Jesús Gutiérrez Hernández, David Fernandez Rivas, Marcel Karperien, Jos Malda, Liliana Moreira Teixeira, Riccardo Levato, Jeroen Leijten   +8 more
wiley   +1 more source

Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After Combination Therapy With Anti-Programmed Death-Ligand 1 and Anti-Vascular Endothelial Growth Factor-A Antibodies. [PDF]

Gastro Hep Adv
Sugiyama G, Nio K, Okada H, Kida A, Sako K, Iwata Y, Takayama H, Kawakami Y, Chiba T, Nagai K, Sugimoto S, Nishitani M, Hayashi T, Takatori H, Shimakami T, Honda M, Yamashita T.   +16 more
europepmc   +1 more source

Penetrance of Severe Pulmonary Arterial Hypertension in Response to Vascular Endothelial Growth Factor Receptor 2 Blockade in a Genetically Prone Rat Model Is Reduced by Female Sex. [PDF]

J Am Heart Assoc, 2021
Chaudhary KR, Deng Y, Yang A, Cober ND, Stewart DJ.   +4 more
europepmc   +1 more source